Maurizio Del Poeta - Concepedia

Author

Maurizio Del Poeta

Also Known As

Del Poeta, Maurizio, Kirk Deitsch, M Del Poeta, M. Del Poeta, Matteo Del Poeta, Maurizio Del Poeta, Maurizio Del Poeta, Maurizio Poeta, Maurizio del Poeta, Shoukat Dedhar

201

Publications

7.7K

Citations

H-Index

Concepts

All Affiliations

Stony Brook University Northport VA Medical Center Medical University of South Carolina Duke Medical Center Universidade Federal do Rio de Janeiro

About

Maurizio Del Poeta is an author at Stony Brook University specializing in medicine, microbiology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	31	1.9K
2	Health Sciences	8	8	666
3	Natural Sciences	5	5	365
4	Public Health	1	1	14
5	Allergy	1	1	41

Maurizio Del Poeta

Publications

5.2K

Citations

H-Index

Page 1

	Year	Citations
Ergosterol Biosynthesis Inhibitors Become Fungicidal when Combined with Calcineurin Inhibitors against <i>Candida albicans</i> , <i>Candida glabrata</i> , and <i>Candida krusei</i> Chiatogu Onyewu, Jill R. Blankenship, Maurizio Del Poeta, Antimicrobial Agents and Chemotherapy	2003	280
Structure-In Vitro Activity Relationships of Pentamidine Analogues and Dication-Substituted Bis-Benzimidazoles as New Antifungal Agents Maurizio Del Poeta, Wiley A. Schell, Christine C. Dykstra, Antimicrobial Agents and Chemotherapy	1998	222
Synergistic Antifungal Activities of Bafilomycin A <sub>1</sub> , Fluconazole, and the Pneumocandin MK-0991/Caspofungin Acetate (L-743,873) with Calcineurin Inhibitors FK506 and L-685,818 against <i>Cryptococcus neoformans</i> Maurizio Del Poeta, Maria Cristina Cruz, María E. Cárdenas, Antimicrobial Agents and Chemotherapy Fungal Cell BiologyMedicinal FungiClinical MycologyAntimicrobial ChemotherapyDrug Resistance	2000	172
In vitro antifungal activity of pneumocandin L-743,872 against a variety of clinically important molds Maurizio Del Poeta, Wiley A. Schell, John R. Perfect Antimicrobial Agents and Chemotherapy Important MoldsVitro Inhibitory ActivityAntifungal AgentAntifungal AgentsMedicine	1997	164
Rapamycin and Less Immunosuppressive Analogs Are Toxic to <i>Candida albicans</i> and <i>Cryptococcus neoformans</i> via FKBP12-Dependent Inhibition of TOR Maria Cristina Cruz, Alan L. Goldstein, Jill R. Blankenship, Antimicrobial Agents and Chemotherapy	2001	160
The immunosuppressant FK506 and its nonimmunosuppressive analog L-685,818 are toxic to Cryptococcus neoformans by inhibition of a common target protein Maurizio Del Poeta, John R. Perfect, Joseph Heitman Antimicrobial Agents and Chemotherapy ImmunologyCalcineurin InhibitorAntimicrobial ChemotherapyImmune SystemImmunotherapy	1997	160
Roles for inositol-phosphoryl ceramide synthase 1 (<i>IPC1</i>) in pathogenesis of<i>C. neoformans</i> Chiara Luberto, Dena L. Toffaletti, Elizabeth A. Wills, Genes & Development Microbial PathogensFungal Cell BiologyEssential Ipc1 GeneImmunologyMolecular Biology	2001	151
Identification of App1 as a regulator of phagocytosis and virulence of Cryptococcus neoformans Chiara Luberto, Beatriz Martinez-Mariño, Daniel Taraskiewicz, Journal of Clinical Investigation	2003	149
Identification of a New Class of Antifungals Targeting the Synthesis of Fungal Sphingolipids Visesato Mor, Antonella Rella, Amir M. Farnoud, mBio	2015	147
Immunosuppressive and Nonimmunosuppressive Cyclosporine Analogs Are Toxic to the Opportunistic Fungal Pathogen<i>Cryptococcus neoformans</i>via Cyclophilin-Dependent Inhibition of Calcineurin Maria Cristina Cruz, Maurizio Del Poeta, Ping Wang, Antimicrobial Agents and Chemotherapy Microbial PathogensImmunologyCyclophilin-dependent InhibitionMedicinal FungiCell Culture	2000	129

Page 1